Clinical Trials

Showing trials with last updates posted in 2017.

NCT01786135 | COMPLETED | PHASE1
64 participants

A Safety Study of SGN-CD19A for B-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2017-10-19
Start Date:
2013-02-28
Completion:
2015-08-31
Conditions
  • Burkitt Lymphoma
  • Lymphoma, Follicular
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Mantle-Cell
  • Precursor B-cell Lymphoblastic Leukemia-Lymphoma
Interventions
  • DRUG
No Results Yet
NCT01551771 | TERMINATED | PHASE1
16 participants

GW824575 First Time in Human

Study Type:
INTERVENTIONAL
Last Updated:
2017-10-19
Start Date:
2012-02-01
Completion:
2012-04-12
Conditions
  • Retinal Diseases
Interventions
  • DRUG
No Results Yet
NCT01101880 | COMPLETED | PHASE2
50 participants

Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm

Study Type:
INTERVENTIONAL
Last Updated:
2017-10-19
Start Date:
2010-08-31
Completion:
2013-06-30
Conditions
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • Adult Acute Myeloid Leukemia With Del(5q)
  • Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
  • Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
  • Chronic Myelomonocytic Leukemia
  • de Novo Myelodysplastic Syndromes
  • Refractory Anemia With Excess Blasts
  • Untreated Adult Acute Myeloid Leukemia
  • Myeloproliferative Neoplasm With 10% Blasts or Higher
Interventions
  • BIOLOGICAL
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page